ProFund Advisors »

Cytomx Therapeutics shares owned by ProFund Advisors

Quarter-by-quarter ownership of Cytomx Therapeutics (CTMX) shares owned by ProFund Advisors from 13F filings

Historical chart of ProFund Advisors investment in Cytomx Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Cytomx Therapeutics held by ProFund Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cytomx Therapeutics by ProFund Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $420k 99k 4.26

More positions owned by ProFund Advisors

NVIDIA Corporation (NVDA)
Apple (AAPL)
Broadcom (AVGO)
Microsoft Corporation (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl C (GOOG)
Advanced Micro Devices (AMD)
Micron Technology (MU)
Netflix (NFLX)
Palantir Technologies Cl A (PLTR)
Cisco Systems (CSCO)
Costco Wholesale Corporation (COST)

View all positions for ProFund Advisors

Top funds holding Cytomx Therapeutics

VR Adviser
FMR
Perceptive Advisors
Vanguard Group
OrbiMed Advisors
Commodore Capital
Point72 Asset Management
State Street Corporation
Balyasny Asset Management
ADAR1 Capital Management
Baker Bros. Advisors
Financial Engines Advisors L.L.C
Kynam Capital Management
Ikarian Capital
Vivo Capital

View all funds holding Cytomx Therapeutics